SCHEMBL4902595

SCHEMBL4902595

CCN(c1ccc(-c2ccc(OC(C)C)cc2)cc1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
TSHR P16473 1/20 0.43
LMNA P02545 4/20 0.42
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ESR1 P03372 2/20 0.42
TP53 P04637 2/20 0.41
RORC P51449 1/20 0.40
PKM P14618 1/20 0.40
MEN1 O00255 1/20 0.40
GAA P10253 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
BCL2L1 Q07817 1/20 0.39
MCL1 Q07820 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
THRB P10828 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4897974 0.90 LMNA (0.51) ALDH1A1LMNAMAPTSMN1; SMN2ESR1
SCHEMBL4898279 0.90 MAPT (0.51) ALDH1A1TSHRLMNAMAPTSMN1; SMN2
SCHEMBL4909029 0.88 ALDH1A1 (0.47) ALDH1A1TSHRLMNAMAPTSMN1; SMN2
SCHEMBL4905482 0.87 NPSR1 (0.51) ALDH1A1TSHRLMNAMAPTESR1
SCHEMBL4906761 0.87 ALDH1A1 (0.48) ALDH1A1TSHRLMNAMAPTSMN1; SMN2
SCHEMBL4902995 0.86 HCRTR2 (0.47) ALDH1A1TSHRLMNAMAPTSMN1; SMN2
SCHEMBL4899803 0.86 HCRTR2 (0.53) ALDH1A1TSHRLMNAMAPTSMN1; SMN2
SCHEMBL4899320 0.85 ALDH1A1 (0.52) ALDH1A1TSHRLMNAMAPTSMN1; SMN2
SCHEMBL4904034 0.85 LMNA (0.50) ALDH1A1TSHRLMNAMAPTESR1
SCHEMBL4900672 0.84 HDAC8 (0.51) ALDH1A1TSHRLMNAMAPTESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885LMNA 319/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885LMNA 319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.